Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dog Diseases | 11 | 2023 | 53 | 3.570 |
Why?
|
Diabetes Mellitus, Type 1 | 8 | 2021 | 593 | 2.340 |
Why?
|
Hepatitis, Alcoholic | 12 | 2024 | 72 | 2.110 |
Why?
|
Edible Grain | 8 | 2011 | 36 | 1.890 |
Why?
|
Cat Diseases | 3 | 2022 | 16 | 1.870 |
Why?
|
Female | 163 | 2024 | 29975 | 1.540 |
Why?
|
Child | 84 | 2023 | 4181 | 1.440 |
Why?
|
Dogs | 13 | 2023 | 305 | 1.430 |
Why?
|
Dietary Fats | 11 | 2011 | 210 | 1.320 |
Why?
|
Adolescent | 68 | 2021 | 5799 | 1.260 |
Why?
|
Male | 109 | 2024 | 26628 | 1.260 |
Why?
|
Obesity | 24 | 2015 | 1184 | 1.240 |
Why?
|
Aspirin | 5 | 2024 | 181 | 1.230 |
Why?
|
Cholesterol, LDL | 18 | 2018 | 115 | 1.230 |
Why?
|
Humans | 199 | 2024 | 57740 | 1.190 |
Why?
|
Child Nutritional Physiological Phenomena | 8 | 2009 | 29 | 1.180 |
Why?
|
Puberty | 14 | 2020 | 57 | 1.140 |
Why?
|
Body Mass Index | 33 | 2017 | 898 | 1.060 |
Why?
|
Echocardiography | 4 | 2020 | 448 | 1.050 |
Why?
|
Adrenalectomy | 2 | 2016 | 26 | 1.040 |
Why?
|
Thromboxanes | 2 | 2024 | 9 | 0.990 |
Why?
|
Analgesics, Opioid | 12 | 2023 | 488 | 0.980 |
Why?
|
End Stage Liver Disease | 5 | 2023 | 27 | 0.980 |
Why?
|
Feeding Behavior | 11 | 2011 | 319 | 0.960 |
Why?
|
Retrospective Studies | 24 | 2023 | 5836 | 0.960 |
Why?
|
Lipids | 6 | 2020 | 302 | 0.910 |
Why?
|
Adult | 69 | 2024 | 15332 | 0.890 |
Why?
|
Longitudinal Studies | 34 | 2021 | 1190 | 0.870 |
Why?
|
Body Composition | 8 | 2017 | 152 | 0.870 |
Why?
|
Research Design | 12 | 2019 | 560 | 0.840 |
Why?
|
Morphine | 10 | 2023 | 52 | 0.800 |
Why?
|
Hyperglycemia | 2 | 2020 | 103 | 0.790 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 2 | 2018 | 12 | 0.790 |
Why?
|
Quarantine | 1 | 2021 | 9 | 0.790 |
Why?
|
Neurofibromatosis 1 | 1 | 2021 | 27 | 0.770 |
Why?
|
Diet, Fat-Restricted | 5 | 2010 | 38 | 0.760 |
Why?
|
Dyslipidemias | 1 | 2020 | 33 | 0.730 |
Why?
|
Quality of Life | 5 | 2021 | 1019 | 0.720 |
Why?
|
Suicidal Ideation | 2 | 2018 | 112 | 0.720 |
Why?
|
Anemia, Sickle Cell | 8 | 2021 | 64 | 0.710 |
Why?
|
Bed Rest | 1 | 2019 | 9 | 0.700 |
Why?
|
Age Factors | 21 | 2023 | 1508 | 0.690 |
Why?
|
Ultrasonography, Doppler, Pulsed | 1 | 2019 | 3 | 0.680 |
Why?
|
Peristalsis | 1 | 2019 | 4 | 0.680 |
Why?
|
Body Weight | 10 | 2014 | 380 | 0.680 |
Why?
|
Cephalosporins | 1 | 2019 | 15 | 0.680 |
Why?
|
Animals | 38 | 2023 | 19306 | 0.670 |
Why?
|
Diet | 12 | 2020 | 651 | 0.670 |
Why?
|
Biomarkers | 13 | 2024 | 1129 | 0.660 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2019 | 46 | 0.660 |
Why?
|
Chickens | 1 | 2019 | 91 | 0.660 |
Why?
|
Gastrointestinal Tract | 2 | 2019 | 166 | 0.650 |
Why?
|
Behavior Therapy | 4 | 2024 | 164 | 0.650 |
Why?
|
Cohort Studies | 25 | 2020 | 2369 | 0.650 |
Why?
|
Brief Psychiatric Rating Scale | 1 | 2018 | 11 | 0.640 |
Why?
|
Rabbits | 1 | 2019 | 323 | 0.640 |
Why?
|
Surveys and Questionnaires | 11 | 2021 | 2512 | 0.640 |
Why?
|
Cardiovascular Diseases | 10 | 2024 | 793 | 0.630 |
Why?
|
Thrombolytic Therapy | 1 | 2019 | 172 | 0.630 |
Why?
|
Ventricular Function, Right | 1 | 2018 | 27 | 0.630 |
Why?
|
Radiology | 3 | 2021 | 230 | 0.630 |
Why?
|
Hypertension, Pulmonary | 2 | 2017 | 71 | 0.620 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2018 | 42 | 0.620 |
Why?
|
Adrenal Gland Neoplasms | 2 | 2016 | 46 | 0.610 |
Why?
|
Depression, Postpartum | 3 | 2016 | 161 | 0.610 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 4 | 2022 | 62 | 0.590 |
Why?
|
Dietary Fiber | 6 | 2011 | 92 | 0.590 |
Why?
|
United States | 37 | 2024 | 7384 | 0.580 |
Why?
|
Energy Intake | 16 | 2020 | 223 | 0.570 |
Why?
|
Blood Glucose | 8 | 2021 | 470 | 0.570 |
Why?
|
Hepatitis C, Chronic | 6 | 2013 | 86 | 0.550 |
Why?
|
Magnetic Resonance Imaging | 5 | 2022 | 1917 | 0.530 |
Why?
|
Veterinarians | 1 | 2015 | 4 | 0.530 |
Why?
|
Opioid-Related Disorders | 4 | 2017 | 456 | 0.530 |
Why?
|
Case-Control Studies | 7 | 2022 | 1029 | 0.530 |
Why?
|
Mass Screening | 4 | 2021 | 629 | 0.530 |
Why?
|
Opiate Substitution Treatment | 2 | 2015 | 187 | 0.530 |
Why?
|
Exercise | 11 | 2024 | 908 | 0.520 |
Why?
|
Brain Ischemia | 1 | 2019 | 393 | 0.520 |
Why?
|
Cattle | 6 | 2020 | 302 | 0.510 |
Why?
|
Risk Assessment | 7 | 2019 | 1875 | 0.510 |
Why?
|
Attitude of Health Personnel | 2 | 2019 | 554 | 0.510 |
Why?
|
Cats | 4 | 2022 | 79 | 0.500 |
Why?
|
Interferon-alpha | 7 | 2013 | 95 | 0.500 |
Why?
|
Emergency Service, Hospital | 5 | 2020 | 1001 | 0.500 |
Why?
|
Maternal Welfare | 1 | 2015 | 14 | 0.500 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2020 | 677 | 0.500 |
Why?
|
Ribavirin | 6 | 2013 | 24 | 0.490 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2015 | 20 | 0.490 |
Why?
|
Emergency Medical Services | 1 | 2018 | 250 | 0.490 |
Why?
|
Cross-Sectional Studies | 18 | 2023 | 2390 | 0.490 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2015 | 31 | 0.490 |
Why?
|
Liver | 6 | 2024 | 756 | 0.490 |
Why?
|
Medicaid | 2 | 2015 | 331 | 0.490 |
Why?
|
Buprenorphine | 2 | 2015 | 184 | 0.480 |
Why?
|
Risk Factors | 26 | 2019 | 4902 | 0.480 |
Why?
|
Middle Aged | 39 | 2024 | 15725 | 0.480 |
Why?
|
Management Audit | 1 | 2014 | 3 | 0.480 |
Why?
|
Peer Review, Health Care | 1 | 2014 | 17 | 0.470 |
Why?
|
Prospective Studies | 22 | 2023 | 2986 | 0.470 |
Why?
|
Vibration | 4 | 2017 | 25 | 0.470 |
Why?
|
Anticoagulants | 5 | 2020 | 477 | 0.470 |
Why?
|
Bone Density | 3 | 2015 | 171 | 0.470 |
Why?
|
Methadone | 1 | 2015 | 125 | 0.470 |
Why?
|
Polyethylene Glycols | 7 | 2013 | 162 | 0.460 |
Why?
|
Blood Pressure | 14 | 2011 | 512 | 0.460 |
Why?
|
Hypercholesterolemia | 5 | 2007 | 74 | 0.460 |
Why?
|
Risk Management | 1 | 2014 | 39 | 0.460 |
Why?
|
Cognition | 6 | 2023 | 454 | 0.460 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 667 | 0.450 |
Why?
|
Aged | 36 | 2024 | 12860 | 0.450 |
Why?
|
Calcium, Dietary | 5 | 2007 | 43 | 0.450 |
Why?
|
Health Care Costs | 1 | 2015 | 196 | 0.440 |
Why?
|
Hip Fractures | 3 | 2010 | 73 | 0.440 |
Why?
|
Infection Control | 4 | 2019 | 89 | 0.430 |
Why?
|
Thromboxane B2 | 3 | 2024 | 19 | 0.430 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 234 | 0.430 |
Why?
|
Adiposity | 2 | 2012 | 78 | 0.430 |
Why?
|
Vancomycin-Resistant Enterococci | 3 | 2018 | 10 | 0.420 |
Why?
|
Antiviral Agents | 7 | 2013 | 300 | 0.420 |
Why?
|
Muscle, Skeletal | 1 | 2017 | 653 | 0.420 |
Why?
|
Cholesterol | 4 | 2010 | 267 | 0.420 |
Why?
|
Disabled Persons | 1 | 2015 | 203 | 0.410 |
Why?
|
Reproducibility of Results | 5 | 2021 | 1503 | 0.390 |
Why?
|
Cross Infection | 3 | 2019 | 140 | 0.390 |
Why?
|
Prognosis | 9 | 2024 | 1521 | 0.390 |
Why?
|
Pain | 5 | 2021 | 405 | 0.380 |
Why?
|
Infant, Newborn | 17 | 2023 | 1284 | 0.380 |
Why?
|
Atrial Fibrillation | 4 | 2020 | 786 | 0.380 |
Why?
|
Metformin | 3 | 2015 | 67 | 0.380 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 1337 | 0.380 |
Why?
|
Treatment Outcome | 23 | 2024 | 4982 | 0.380 |
Why?
|
Dietary Proteins | 3 | 2003 | 53 | 0.370 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2021 | 58 | 0.370 |
Why?
|
Severity of Illness Index | 12 | 2023 | 1362 | 0.370 |
Why?
|
Milk | 3 | 2020 | 50 | 0.360 |
Why?
|
Accidental Falls | 3 | 2017 | 145 | 0.360 |
Why?
|
Gonadal Hormones | 1 | 2010 | 5 | 0.360 |
Why?
|
Young Adult | 11 | 2021 | 4215 | 0.360 |
Why?
|
Conscious Sedation | 3 | 2019 | 49 | 0.350 |
Why?
|
Breast Neoplasms | 4 | 2023 | 1125 | 0.350 |
Why?
|
Child, Preschool | 13 | 2021 | 1787 | 0.350 |
Why?
|
Child Nutrition Sciences | 1 | 2009 | 4 | 0.350 |
Why?
|
Feeding and Eating Disorders | 5 | 2012 | 47 | 0.340 |
Why?
|
Choline | 2 | 2020 | 20 | 0.340 |
Why?
|
Beverages | 2 | 2007 | 63 | 0.340 |
Why?
|
Quality Improvement | 1 | 2014 | 407 | 0.340 |
Why?
|
Aging | 5 | 2017 | 712 | 0.340 |
Why?
|
Non-alcoholic Fatty Liver Disease | 2 | 2021 | 68 | 0.340 |
Why?
|
Atrial Remodeling | 2 | 2020 | 17 | 0.340 |
Why?
|
Insulin | 5 | 2021 | 681 | 0.330 |
Why?
|
Body Height | 8 | 2012 | 75 | 0.330 |
Why?
|
Time Factors | 12 | 2019 | 3518 | 0.330 |
Why?
|
Breast | 2 | 2010 | 174 | 0.330 |
Why?
|
Parity | 4 | 2017 | 71 | 0.330 |
Why?
|
Nutritional Status | 4 | 2008 | 120 | 0.330 |
Why?
|
Pregnancy | 18 | 2023 | 2311 | 0.330 |
Why?
|
Patient Education as Topic | 4 | 2020 | 456 | 0.330 |
Why?
|
Homes for the Aged | 2 | 2008 | 163 | 0.330 |
Why?
|
Patient Portals | 2 | 2020 | 45 | 0.320 |
Why?
|
Sex Factors | 12 | 2019 | 942 | 0.320 |
Why?
|
Venous Thromboembolism | 2 | 2020 | 138 | 0.320 |
Why?
|
Geriatric Assessment | 2 | 2019 | 162 | 0.320 |
Why?
|
Reminder Systems | 2 | 2020 | 71 | 0.320 |
Why?
|
Patient Compliance | 3 | 2012 | 377 | 0.310 |
Why?
|
Hepatitis | 3 | 2023 | 54 | 0.310 |
Why?
|
Patient Acceptance of Health Care | 2 | 2019 | 444 | 0.310 |
Why?
|
Hydrocortisone | 5 | 2016 | 189 | 0.310 |
Why?
|
Protective Devices | 1 | 2008 | 12 | 0.310 |
Why?
|
Referral and Consultation | 3 | 2020 | 395 | 0.310 |
Why?
|
Nursing Homes | 3 | 2010 | 654 | 0.300 |
Why?
|
Smoking Cessation | 3 | 2020 | 535 | 0.300 |
Why?
|
Stress, Psychological | 4 | 2019 | 435 | 0.300 |
Why?
|
Infant, Premature | 9 | 2008 | 168 | 0.300 |
Why?
|
Reference Values | 5 | 2017 | 318 | 0.300 |
Why?
|
Cholesterol, HDL | 10 | 2010 | 80 | 0.290 |
Why?
|
Double-Blind Method | 12 | 2024 | 631 | 0.290 |
Why?
|
Aged, 80 and over | 16 | 2019 | 4953 | 0.290 |
Why?
|
Frailty | 2 | 2019 | 126 | 0.290 |
Why?
|
Vaccination | 2 | 2020 | 326 | 0.280 |
Why?
|
Life Style | 3 | 2024 | 334 | 0.280 |
Why?
|
Creatinine | 2 | 2024 | 120 | 0.280 |
Why?
|
Weight Loss | 2 | 2014 | 265 | 0.270 |
Why?
|
Follow-Up Studies | 11 | 2018 | 2255 | 0.270 |
Why?
|
Gram-Positive Bacterial Infections | 2 | 2017 | 29 | 0.260 |
Why?
|
Stress, Physiological | 3 | 2004 | 186 | 0.260 |
Why?
|
Fishes | 3 | 2000 | 23 | 0.260 |
Why?
|
Complement System Proteins | 2 | 2024 | 126 | 0.260 |
Why?
|
Alcoholism | 4 | 2024 | 305 | 0.260 |
Why?
|
Pulmonary Artery | 2 | 2017 | 80 | 0.260 |
Why?
|
Diet Records | 9 | 2010 | 51 | 0.260 |
Why?
|
Analgesia | 2 | 2023 | 31 | 0.260 |
Why?
|
Pediatric Obesity | 3 | 2016 | 93 | 0.260 |
Why?
|
Body Weights and Measures | 3 | 2021 | 34 | 0.250 |
Why?
|
Age Distribution | 4 | 2015 | 261 | 0.250 |
Why?
|
Nutritive Value | 4 | 2009 | 31 | 0.250 |
Why?
|
Pain, Postoperative | 2 | 2023 | 126 | 0.250 |
Why?
|
Antisickling Agents | 3 | 2009 | 6 | 0.240 |
Why?
|
Antipsychotic Agents | 3 | 2013 | 313 | 0.240 |
Why?
|
Biological Specimen Banks | 1 | 2024 | 17 | 0.240 |
Why?
|
Hydroxyurea | 3 | 2009 | 23 | 0.240 |
Why?
|
Wharton Jelly | 2 | 2021 | 3 | 0.240 |
Why?
|
Specimen Handling | 1 | 2024 | 56 | 0.240 |
Why?
|
Laparoscopy | 2 | 2019 | 387 | 0.230 |
Why?
|
Bupivacaine | 2 | 2023 | 32 | 0.230 |
Why?
|
Pilot Projects | 4 | 2023 | 899 | 0.230 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 2009 | 136 | 0.230 |
Why?
|
Administration, Oral | 3 | 2019 | 337 | 0.230 |
Why?
|
Amino Acids, Aromatic | 1 | 2023 | 8 | 0.230 |
Why?
|
Interleukin-13 | 1 | 2023 | 34 | 0.230 |
Why?
|
Regression Analysis | 13 | 2009 | 479 | 0.230 |
Why?
|
Factor Analysis, Statistical | 2 | 2021 | 101 | 0.230 |
Why?
|
Emergency Medicine | 2 | 2017 | 183 | 0.220 |
Why?
|
Prevalence | 10 | 2019 | 1264 | 0.220 |
Why?
|
Parents | 4 | 2016 | 369 | 0.220 |
Why?
|
Congenital Hypothyroidism | 1 | 2023 | 13 | 0.220 |
Why?
|
Triglycerides | 10 | 2017 | 247 | 0.220 |
Why?
|
Vasospasm, Intracranial | 2 | 2014 | 24 | 0.220 |
Why?
|
Thyroid Diseases | 1 | 2023 | 26 | 0.220 |
Why?
|
Nutrition Policy | 4 | 2008 | 49 | 0.220 |
Why?
|
Random Allocation | 2 | 2023 | 198 | 0.220 |
Why?
|
Hypothyroidism | 1 | 2023 | 38 | 0.210 |
Why?
|
Staphylococcal Infections | 2 | 2022 | 109 | 0.210 |
Why?
|
Dietary Carbohydrates | 1 | 2003 | 82 | 0.210 |
Why?
|
Weight Gain | 3 | 2015 | 161 | 0.210 |
Why?
|
Administration, Intravenous | 2 | 2021 | 57 | 0.210 |
Why?
|
Probiotics | 1 | 2023 | 38 | 0.210 |
Why?
|
Self Concept | 4 | 2016 | 104 | 0.210 |
Why?
|
Pentoxifylline | 1 | 2022 | 9 | 0.210 |
Why?
|
Combined Modality Therapy | 4 | 2015 | 349 | 0.210 |
Why?
|
Hypnotics and Sedatives | 3 | 2018 | 70 | 0.210 |
Why?
|
Pharmacists | 2 | 2020 | 122 | 0.210 |
Why?
|
Proteomics | 1 | 2024 | 239 | 0.210 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2023 | 82 | 0.210 |
Why?
|
Down Syndrome | 1 | 2023 | 49 | 0.200 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2014 | 84 | 0.200 |
Why?
|
Pneumonia, Staphylococcal | 1 | 2022 | 12 | 0.200 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 124 | 0.200 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2017 | 236 | 0.200 |
Why?
|
Text Messaging | 2 | 2020 | 73 | 0.200 |
Why?
|
Antimanic Agents | 1 | 2002 | 29 | 0.200 |
Why?
|
Infant, Premature, Diseases | 4 | 2007 | 45 | 0.200 |
Why?
|
Mobile Applications | 2 | 2024 | 115 | 0.200 |
Why?
|
Fatty Liver | 2 | 2021 | 97 | 0.200 |
Why?
|
Kidney | 1 | 2024 | 386 | 0.200 |
Why?
|
Predictive Value of Tests | 5 | 2019 | 975 | 0.200 |
Why?
|
Atrial Function, Left | 2 | 2020 | 31 | 0.200 |
Why?
|
Equipment and Supplies | 2 | 2012 | 17 | 0.200 |
Why?
|
Insulin Infusion Systems | 1 | 2021 | 10 | 0.200 |
Why?
|
National Institutes of Health (U.S.) | 7 | 2024 | 110 | 0.200 |
Why?
|
Infant | 8 | 2023 | 1488 | 0.200 |
Why?
|
Tay-Sachs Disease | 1 | 2022 | 34 | 0.200 |
Why?
|
Soft Tissue Infections | 1 | 2022 | 42 | 0.200 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 38 | 0.190 |
Why?
|
Orthotic Devices | 1 | 2021 | 9 | 0.190 |
Why?
|
Plagiocephaly | 1 | 2021 | 5 | 0.190 |
Why?
|
Head Protective Devices | 1 | 2021 | 19 | 0.190 |
Why?
|
Poloxamer | 1 | 2021 | 12 | 0.190 |
Why?
|
Community-Acquired Infections | 1 | 2022 | 85 | 0.190 |
Why?
|
Pregnancy Complications | 2 | 2017 | 384 | 0.190 |
Why?
|
Communicable Disease Control | 1 | 2021 | 37 | 0.190 |
Why?
|
Bacteremia | 1 | 2022 | 91 | 0.190 |
Why?
|
Internship and Residency | 3 | 2021 | 696 | 0.190 |
Why?
|
Hypoglycemic Agents | 2 | 2017 | 208 | 0.190 |
Why?
|
Vasodilator Agents | 1 | 2021 | 57 | 0.190 |
Why?
|
Head | 1 | 2021 | 49 | 0.190 |
Why?
|
Influenza, Human | 2 | 2020 | 184 | 0.190 |
Why?
|
Interviews as Topic | 2 | 2021 | 471 | 0.190 |
Why?
|
Patient Transfer | 2 | 2020 | 91 | 0.190 |
Why?
|
Gluconeogenesis | 1 | 2020 | 15 | 0.190 |
Why?
|
House Calls | 1 | 2020 | 17 | 0.190 |
Why?
|
Dietary Supplements | 3 | 2020 | 244 | 0.180 |
Why?
|
History, 21st Century | 1 | 2021 | 160 | 0.180 |
Why?
|
Caffeine | 2 | 2006 | 45 | 0.180 |
Why?
|
Drug Therapy, Combination | 7 | 2013 | 408 | 0.180 |
Why?
|
Age of Onset | 1 | 2020 | 171 | 0.180 |
Why?
|
Health Status | 4 | 2014 | 441 | 0.180 |
Why?
|
Breeding | 2 | 2018 | 26 | 0.180 |
Why?
|
Gastrointestinal Microbiome | 1 | 2023 | 179 | 0.180 |
Why?
|
Psychotic Disorders | 1 | 2002 | 147 | 0.180 |
Why?
|
Osteoporosis | 2 | 2012 | 137 | 0.180 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 308 | 0.180 |
Why?
|
Fatty Liver, Alcoholic | 1 | 2020 | 33 | 0.180 |
Why?
|
Thrombocytosis | 1 | 2020 | 3 | 0.180 |
Why?
|
Overweight | 2 | 2016 | 244 | 0.180 |
Why?
|
Gastropexy | 1 | 2019 | 1 | 0.180 |
Why?
|
Stomach Volvulus | 1 | 2019 | 3 | 0.180 |
Why?
|
Placebos | 6 | 2021 | 71 | 0.180 |
Why?
|
Health Behavior | 4 | 2024 | 476 | 0.180 |
Why?
|
Protein Kinases | 1 | 2021 | 137 | 0.180 |
Why?
|
Pandemics | 2 | 2023 | 594 | 0.180 |
Why?
|
Thrombophilia | 1 | 2020 | 15 | 0.170 |
Why?
|
Adipose Tissue | 7 | 2002 | 283 | 0.170 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 121 | 0.170 |
Why?
|
Respiration, Artificial | 6 | 2007 | 279 | 0.170 |
Why?
|
Hypertension | 4 | 2015 | 595 | 0.170 |
Why?
|
Patient Care | 1 | 2020 | 75 | 0.170 |
Why?
|
Safety Management | 2 | 2014 | 144 | 0.170 |
Why?
|
Recurrence | 5 | 2015 | 560 | 0.170 |
Why?
|
Eating | 4 | 2012 | 142 | 0.170 |
Why?
|
Diagnosis, Differential | 1 | 2022 | 870 | 0.170 |
Why?
|
Mental Health | 2 | 2019 | 343 | 0.170 |
Why?
|
Deep Sedation | 1 | 2019 | 8 | 0.170 |
Why?
|
Forelimb | 1 | 2019 | 8 | 0.170 |
Why?
|
Synovial Fluid | 1 | 2019 | 29 | 0.170 |
Why?
|
Molecular Typing | 1 | 2019 | 8 | 0.170 |
Why?
|
Sexual Maturation | 5 | 2003 | 50 | 0.170 |
Why?
|
Bipolar Disorder | 1 | 2002 | 249 | 0.170 |
Why?
|
Acute-Phase Proteins | 1 | 2019 | 33 | 0.170 |
Why?
|
Electronic Nicotine Delivery Systems | 1 | 2020 | 68 | 0.170 |
Why?
|
Perfusion | 1 | 2019 | 76 | 0.160 |
Why?
|
Sample Size | 3 | 2019 | 59 | 0.160 |
Why?
|
Stroke | 5 | 2019 | 1121 | 0.160 |
Why?
|
Coronary Occlusion | 2 | 2009 | 7 | 0.160 |
Why?
|
Whole Genome Sequencing | 1 | 2019 | 54 | 0.160 |
Why?
|
Lipid Metabolism | 1 | 2020 | 202 | 0.160 |
Why?
|
Health Expenditures | 2 | 2024 | 114 | 0.160 |
Why?
|
Gyrus Cinguli | 1 | 2019 | 57 | 0.160 |
Why?
|
Surgical Wound Infection | 1 | 2019 | 101 | 0.160 |
Why?
|
Activities of Daily Living | 3 | 2016 | 297 | 0.160 |
Why?
|
Genome, Bacterial | 1 | 2019 | 63 | 0.160 |
Why?
|
Estradiol | 4 | 2010 | 240 | 0.160 |
Why?
|
Interrupted Time Series Analysis | 2 | 2019 | 27 | 0.160 |
Why?
|
Macrophage Activation | 1 | 2019 | 119 | 0.160 |
Why?
|
Cerebral Infarction | 2 | 2010 | 74 | 0.160 |
Why?
|
Testosterone | 4 | 2009 | 115 | 0.160 |
Why?
|
Protective Clothing | 2 | 2010 | 28 | 0.160 |
Why?
|
Socioeconomic Factors | 7 | 2015 | 783 | 0.160 |
Why?
|
Heart Failure | 4 | 2021 | 848 | 0.160 |
Why?
|
Cigarette Smoking | 1 | 2019 | 49 | 0.160 |
Why?
|
Cues | 1 | 2019 | 72 | 0.160 |
Why?
|
Adenosine | 1 | 2019 | 67 | 0.160 |
Why?
|
Micronutrients | 2 | 2009 | 29 | 0.160 |
Why?
|
Extracellular Vesicles | 1 | 2019 | 39 | 0.160 |
Why?
|
Continuity of Patient Care | 1 | 2020 | 167 | 0.160 |
Why?
|
Massachusetts | 6 | 2019 | 2088 | 0.160 |
Why?
|
Hepatitis C | 2 | 2011 | 135 | 0.160 |
Why?
|
Phlebotomy | 1 | 2018 | 11 | 0.150 |
Why?
|
Mindfulness | 1 | 2019 | 65 | 0.150 |
Why?
|
Comorbidity | 4 | 2019 | 1084 | 0.150 |
Why?
|
Injections, Intramuscular | 1 | 2018 | 69 | 0.150 |
Why?
|
Transforming Growth Factor beta | 1 | 2019 | 156 | 0.150 |
Why?
|
Sensitivity and Specificity | 4 | 2023 | 1058 | 0.150 |
Why?
|
Thromboxane A2 | 1 | 2017 | 7 | 0.150 |
Why?
|
Antigens, CD | 1 | 2019 | 334 | 0.150 |
Why?
|
Brain | 3 | 2022 | 1432 | 0.150 |
Why?
|
Data Collection | 2 | 2022 | 381 | 0.150 |
Why?
|
Ataxia | 1 | 2017 | 23 | 0.150 |
Why?
|
Health Policy | 1 | 2019 | 178 | 0.150 |
Why?
|
Suicide, Attempted | 1 | 2018 | 98 | 0.150 |
Why?
|
Deficiency Diseases | 1 | 2017 | 12 | 0.150 |
Why?
|
Metabolic Syndrome | 2 | 2011 | 151 | 0.150 |
Why?
|
Iodine | 1 | 2017 | 22 | 0.150 |
Why?
|
Myocardial Infarction | 5 | 2017 | 843 | 0.150 |
Why?
|
Disease Progression | 2 | 2019 | 937 | 0.150 |
Why?
|
Heart Atria | 1 | 2018 | 136 | 0.150 |
Why?
|
Lung Neoplasms | 1 | 2023 | 534 | 0.150 |
Why?
|
Electronic Health Records | 1 | 2020 | 341 | 0.140 |
Why?
|
Aorta, Thoracic | 1 | 2017 | 74 | 0.140 |
Why?
|
Touch | 1 | 2017 | 28 | 0.140 |
Why?
|
Social Support | 2 | 2019 | 354 | 0.140 |
Why?
|
Depressive Disorder, Major | 2 | 2013 | 259 | 0.140 |
Why?
|
Simvastatin | 1 | 2017 | 28 | 0.140 |
Why?
|
Influenza Vaccines | 1 | 2018 | 84 | 0.140 |
Why?
|
Mexican Americans | 1 | 2016 | 19 | 0.140 |
Why?
|
Neonatal Abstinence Syndrome | 1 | 2017 | 32 | 0.140 |
Why?
|
Postpartum Period | 2 | 2017 | 198 | 0.140 |
Why?
|
Clinical Competence | 2 | 2015 | 653 | 0.140 |
Why?
|
Recombinant Proteins | 7 | 2013 | 683 | 0.140 |
Why?
|
Carbonated Beverages | 2 | 2007 | 20 | 0.140 |
Why?
|
Decision Support Techniques | 1 | 2018 | 171 | 0.140 |
Why?
|
Diet Surveys | 3 | 2007 | 82 | 0.140 |
Why?
|
Guideline Adherence | 2 | 2010 | 289 | 0.140 |
Why?
|
Gait | 1 | 2017 | 114 | 0.140 |
Why?
|
Fertility | 1 | 1996 | 82 | 0.140 |
Why?
|
Diphtheria Toxin | 1 | 2016 | 4 | 0.140 |
Why?
|
Diphtheria Antitoxin | 1 | 2016 | 2 | 0.140 |
Why?
|
Diphtheria | 1 | 2016 | 3 | 0.140 |
Why?
|
Georgia | 3 | 2022 | 87 | 0.140 |
Why?
|
Autoantibodies | 2 | 2017 | 173 | 0.140 |
Why?
|
Mobility Limitation | 1 | 2016 | 49 | 0.140 |
Why?
|
Quality of Health Care | 1 | 2020 | 502 | 0.140 |
Why?
|
Communication Barriers | 1 | 2016 | 56 | 0.140 |
Why?
|
Pancreatitis, Chronic | 1 | 2016 | 24 | 0.130 |
Why?
|
Lactation | 4 | 2020 | 70 | 0.130 |
Why?
|
Fear | 1 | 2016 | 64 | 0.130 |
Why?
|
Patient Satisfaction | 1 | 2019 | 413 | 0.130 |
Why?
|
Steroids | 1 | 2016 | 52 | 0.130 |
Why?
|
Bulimia Nervosa | 2 | 2006 | 10 | 0.130 |
Why?
|
Postoperative Period | 1 | 2016 | 125 | 0.130 |
Why?
|
Hotlines | 1 | 2016 | 22 | 0.130 |
Why?
|
Gestational Age | 5 | 2023 | 178 | 0.130 |
Why?
|
Pregnancy Outcome | 2 | 2009 | 186 | 0.130 |
Why?
|
Membrane Glycoproteins | 1 | 2019 | 663 | 0.130 |
Why?
|
Directive Counseling | 1 | 2016 | 40 | 0.130 |
Why?
|
Mental Health Services | 1 | 2019 | 296 | 0.130 |
Why?
|
Cognitive Dysfunction | 1 | 2019 | 250 | 0.130 |
Why?
|
Observational Studies as Topic | 1 | 2015 | 55 | 0.130 |
Why?
|
Coronary Artery Bypass | 1 | 2017 | 262 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2012 | 639 | 0.130 |
Why?
|
School Health Services | 1 | 2016 | 62 | 0.130 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2016 | 78 | 0.130 |
Why?
|
Logistic Models | 7 | 2017 | 1253 | 0.130 |
Why?
|
Educational Status | 4 | 2023 | 271 | 0.130 |
Why?
|
Progesterone | 3 | 2016 | 156 | 0.130 |
Why?
|
Cecal Neoplasms | 1 | 2015 | 1 | 0.130 |
Why?
|
Duodenal Neoplasms | 1 | 2015 | 5 | 0.130 |
Why?
|
Jejunal Neoplasms | 1 | 2015 | 4 | 0.130 |
Why?
|
Fibrosarcoma | 1 | 2015 | 13 | 0.130 |
Why?
|
Patient Admission | 1 | 2017 | 183 | 0.130 |
Why?
|
Confidence Intervals | 2 | 2015 | 258 | 0.130 |
Why?
|
Leiomyosarcoma | 1 | 2015 | 9 | 0.130 |
Why?
|
Hyperaldosteronism | 1 | 2015 | 5 | 0.130 |
Why?
|
Learning Curve | 1 | 2015 | 21 | 0.130 |
Why?
|
Hypokalemia | 1 | 2015 | 13 | 0.130 |
Why?
|
Leiomyoma | 1 | 2015 | 17 | 0.120 |
Why?
|
Liver Cirrhosis | 2 | 2013 | 147 | 0.120 |
Why?
|
Health Promotion | 3 | 2016 | 493 | 0.120 |
Why?
|
Vegetables | 2 | 2006 | 91 | 0.120 |
Why?
|
Bronchitis, Chronic | 1 | 2014 | 4 | 0.120 |
Why?
|
Coxsackievirus Infections | 1 | 2014 | 12 | 0.120 |
Why?
|
Gonadal Steroid Hormones | 2 | 2006 | 29 | 0.120 |
Why?
|
Dantrolene | 1 | 2014 | 7 | 0.120 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 599 | 0.120 |
Why?
|
Fruit | 2 | 2006 | 118 | 0.120 |
Why?
|
Muscle Relaxants, Central | 1 | 2014 | 12 | 0.120 |
Why?
|
Rhode Island | 1 | 2015 | 95 | 0.120 |
Why?
|
Body Fat Distribution | 2 | 2012 | 11 | 0.120 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 214 | 0.120 |
Why?
|
Sarcoma | 1 | 2015 | 54 | 0.120 |
Why?
|
Sex Hormone-Binding Globulin | 3 | 2010 | 17 | 0.120 |
Why?
|
Adenoma | 1 | 2015 | 62 | 0.120 |
Why?
|
Cell Proliferation | 1 | 2019 | 927 | 0.120 |
Why?
|
Pressure Ulcer | 1 | 2014 | 35 | 0.120 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 253 | 0.120 |
Why?
|
Bronchi | 1 | 2014 | 67 | 0.120 |
Why?
|
Pulse | 1 | 1994 | 13 | 0.120 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2011 | 730 | 0.120 |
Why?
|
Carrier Proteins | 1 | 2019 | 707 | 0.120 |
Why?
|
Blood Transfusion | 2 | 2018 | 144 | 0.120 |
Why?
|
Hepacivirus | 3 | 2013 | 137 | 0.120 |
Why?
|
Vitiligo | 1 | 2017 | 117 | 0.120 |
Why?
|
Stomach Neoplasms | 1 | 2015 | 84 | 0.120 |
Why?
|
Drug and Narcotic Control | 1 | 2014 | 31 | 0.120 |
Why?
|
Fingers | 1 | 1994 | 39 | 0.120 |
Why?
|
Zinc | 3 | 2024 | 87 | 0.120 |
Why?
|
MicroRNAs | 1 | 2020 | 615 | 0.120 |
Why?
|
Maternal Health Services | 1 | 2015 | 64 | 0.120 |
Why?
|
Endpoint Determination | 1 | 2014 | 20 | 0.120 |
Why?
|
Yttrium Radioisotopes | 1 | 2013 | 7 | 0.110 |
Why?
|
Rectal Neoplasms | 1 | 2015 | 95 | 0.110 |
Why?
|
Self Report | 2 | 2014 | 359 | 0.110 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2014 | 170 | 0.110 |
Why?
|
Pain Measurement | 4 | 2009 | 329 | 0.110 |
Why?
|
Multivariate Analysis | 4 | 2019 | 912 | 0.110 |
Why?
|
Morpholinos | 1 | 2013 | 50 | 0.110 |
Why?
|
Crime | 1 | 2014 | 63 | 0.110 |
Why?
|
Sertraline | 1 | 2013 | 59 | 0.110 |
Why?
|
Growth | 3 | 2002 | 22 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 4 | 2019 | 388 | 0.110 |
Why?
|
Criminal Law | 1 | 2014 | 90 | 0.110 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 2 | 2024 | 25 | 0.110 |
Why?
|
Perception | 1 | 2014 | 179 | 0.110 |
Why?
|
Lymphoproliferative Disorders | 1 | 2013 | 33 | 0.110 |
Why?
|
Benzodiazepines | 1 | 2013 | 96 | 0.110 |
Why?
|
Islets of Langerhans | 1 | 2014 | 262 | 0.110 |
Why?
|
Birth Weight | 3 | 2023 | 82 | 0.110 |
Why?
|
Immunohistochemistry | 1 | 2015 | 839 | 0.110 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2012 | 24 | 0.110 |
Why?
|
Odds Ratio | 4 | 2019 | 788 | 0.110 |
Why?
|
Ultrasonography | 1 | 2015 | 444 | 0.110 |
Why?
|
Central Nervous System Diseases | 1 | 2013 | 55 | 0.110 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2012 | 46 | 0.110 |
Why?
|
Organ Transplantation | 1 | 2013 | 51 | 0.110 |
Why?
|
Health Services Research | 1 | 2014 | 268 | 0.110 |
Why?
|
Patient Selection | 2 | 2012 | 432 | 0.100 |
Why?
|
Hospitalization | 1 | 2020 | 1230 | 0.100 |
Why?
|
Postoperative Complications | 2 | 2016 | 1109 | 0.100 |
Why?
|
Growth Disorders | 1 | 2012 | 30 | 0.100 |
Why?
|
Proportional Hazards Models | 4 | 2019 | 660 | 0.100 |
Why?
|
Depression | 3 | 2019 | 855 | 0.100 |
Why?
|
Databases, Factual | 2 | 2015 | 843 | 0.100 |
Why?
|
Mammary Glands, Human | 1 | 2012 | 50 | 0.100 |
Why?
|
Absorptiometry, Photon | 1 | 2012 | 86 | 0.100 |
Why?
|
Medical Errors | 1 | 2014 | 182 | 0.100 |
Why?
|
Nutritional Requirements | 2 | 2008 | 30 | 0.100 |
Why?
|
Dementia | 1 | 2015 | 240 | 0.100 |
Why?
|
Skinfold Thickness | 9 | 2005 | 16 | 0.100 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 859 | 0.100 |
Why?
|
Anesthetics, Local | 2 | 2023 | 63 | 0.100 |
Why?
|
Psychotherapy | 1 | 2012 | 89 | 0.100 |
Why?
|
Behavior | 1 | 2011 | 38 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 215 | 0.100 |
Why?
|
Videodisc Recording | 1 | 2011 | 8 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 651 | 0.090 |
Why?
|
Guidelines as Topic | 1 | 2012 | 159 | 0.090 |
Why?
|
Stroke Volume | 3 | 2009 | 302 | 0.090 |
Why?
|
Perches | 1 | 2010 | 1 | 0.090 |
Why?
|
Biogenic Monoamines | 1 | 2010 | 5 | 0.090 |
Why?
|
Arrhythmias, Cardiac | 2 | 2018 | 143 | 0.090 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 414 | 0.090 |
Why?
|
Neoplastic Stem Cells | 1 | 2012 | 200 | 0.090 |
Why?
|
Cluster Analysis | 2 | 2023 | 242 | 0.090 |
Why?
|
Neoplasm Proteins | 1 | 2012 | 274 | 0.090 |
Why?
|
Matched-Pair Analysis | 2 | 2008 | 6 | 0.090 |
Why?
|
Trace Elements | 3 | 2007 | 18 | 0.090 |
Why?
|
Neurotransmitter Agents | 1 | 2010 | 41 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2011 | 148 | 0.090 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2012 | 158 | 0.090 |
Why?
|
Insulin Resistance | 4 | 2011 | 398 | 0.090 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2011 | 137 | 0.090 |
Why?
|
Nicotine | 1 | 2011 | 110 | 0.090 |
Why?
|
Health Literacy | 1 | 2011 | 76 | 0.090 |
Why?
|
Waist Circumference | 1 | 2010 | 56 | 0.090 |
Why?
|
Hypothalamus | 1 | 2010 | 120 | 0.090 |
Why?
|
Sickness Impact Profile | 2 | 2009 | 45 | 0.090 |
Why?
|
Primary Health Care | 1 | 2016 | 626 | 0.090 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2009 | 5 | 0.090 |
Why?
|
Health Services Accessibility | 1 | 2015 | 535 | 0.090 |
Why?
|
Incidence | 4 | 2018 | 1216 | 0.090 |
Why?
|
Neoplasms | 1 | 2019 | 1183 | 0.090 |
Why?
|
Coronary Restenosis | 1 | 2009 | 17 | 0.080 |
Why?
|
Family Relations | 1 | 2009 | 22 | 0.080 |
Why?
|
Metals | 1 | 2009 | 60 | 0.080 |
Why?
|
Body Constitution | 3 | 1998 | 15 | 0.080 |
Why?
|
Ethanol | 2 | 2023 | 303 | 0.080 |
Why?
|
Circadian Rhythm | 2 | 2004 | 367 | 0.080 |
Why?
|
Drug-Eluting Stents | 1 | 2009 | 44 | 0.080 |
Why?
|
Medication Adherence | 1 | 2011 | 255 | 0.080 |
Why?
|
Anesthesia, Obstetrical | 1 | 1988 | 24 | 0.080 |
Why?
|
Saliva | 2 | 2021 | 91 | 0.080 |
Why?
|
Emotions | 1 | 2011 | 215 | 0.080 |
Why?
|
Food Analysis | 1 | 2008 | 38 | 0.080 |
Why?
|
Coronary Angiography | 1 | 2009 | 150 | 0.080 |
Why?
|
Anesthesia, Spinal | 1 | 1988 | 28 | 0.080 |
Why?
|
Peripartum Period | 2 | 2020 | 30 | 0.080 |
Why?
|
Child Behavior | 1 | 2009 | 67 | 0.080 |
Why?
|
Vitamins | 2 | 2007 | 84 | 0.080 |
Why?
|
Intensive Care, Neonatal | 2 | 2007 | 10 | 0.080 |
Why?
|
Juvenile Delinquency | 1 | 2009 | 55 | 0.080 |
Why?
|
Food Preferences | 2 | 2006 | 55 | 0.080 |
Why?
|
Labor, Obstetric | 1 | 1988 | 40 | 0.080 |
Why?
|
beta-Thalassemia | 1 | 2008 | 11 | 0.080 |
Why?
|
Meta-Analysis as Topic | 1 | 2008 | 74 | 0.080 |
Why?
|
Nutrition Surveys | 3 | 2017 | 151 | 0.080 |
Why?
|
Education, Medical, Graduate | 4 | 2021 | 293 | 0.080 |
Why?
|
Radiology Information Systems | 1 | 2008 | 28 | 0.080 |
Why?
|
Cholesterol, Dietary | 3 | 2003 | 30 | 0.080 |
Why?
|
Ventricular Remodeling | 1 | 2008 | 79 | 0.080 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2007 | 15 | 0.080 |
Why?
|
Multicenter Studies as Topic | 1 | 2008 | 104 | 0.070 |
Why?
|
Cardiovascular Agents | 1 | 2008 | 94 | 0.070 |
Why?
|
Mammography | 1 | 2010 | 272 | 0.070 |
Why?
|
ROC Curve | 2 | 2019 | 250 | 0.070 |
Why?
|
Social Environment | 1 | 2008 | 92 | 0.070 |
Why?
|
Cause of Death | 2 | 2019 | 194 | 0.070 |
Why?
|
Enteral Nutrition | 1 | 2007 | 54 | 0.070 |
Why?
|
Adolescent Behavior | 2 | 2006 | 188 | 0.070 |
Why?
|
Lipopolysaccharides | 1 | 2010 | 640 | 0.070 |
Why?
|
Nutrition Assessment | 1 | 2007 | 62 | 0.070 |
Why?
|
Panic Disorder | 2 | 2005 | 30 | 0.070 |
Why?
|
Remission Induction | 2 | 2017 | 135 | 0.070 |
Why?
|
Bone Density Conservation Agents | 1 | 2007 | 47 | 0.070 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2023 | 72 | 0.070 |
Why?
|
Thyroxine | 2 | 2023 | 52 | 0.070 |
Why?
|
Mental Recall | 1 | 2007 | 102 | 0.070 |
Why?
|
Caregivers | 1 | 2009 | 205 | 0.070 |
Why?
|
Sex Distribution | 1 | 2007 | 256 | 0.070 |
Why?
|
Choice Behavior | 1 | 2007 | 76 | 0.070 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2006 | 50 | 0.070 |
Why?
|
Anorexia Nervosa | 1 | 2006 | 14 | 0.070 |
Why?
|
Cardiac Output, Low | 1 | 2006 | 10 | 0.070 |
Why?
|
Drinking Behavior | 1 | 2006 | 9 | 0.070 |
Why?
|
Family | 1 | 2008 | 213 | 0.070 |
Why?
|
Healthy People Programs | 1 | 2006 | 12 | 0.070 |
Why?
|
Bulimia | 1 | 2006 | 15 | 0.070 |
Why?
|
Pediatrics | 3 | 2016 | 253 | 0.070 |
Why?
|
Anthropometry | 4 | 2015 | 80 | 0.070 |
Why?
|
Salmon | 1 | 1985 | 8 | 0.070 |
Why?
|
Demography | 4 | 2015 | 182 | 0.070 |
Why?
|
Stents | 1 | 2009 | 410 | 0.070 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 1985 | 22 | 0.060 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2005 | 8 | 0.060 |
Why?
|
Postmenopause | 2 | 2005 | 253 | 0.060 |
Why?
|
Diet, Atherogenic | 1 | 2005 | 7 | 0.060 |
Why?
|
Blood Specimen Collection | 1 | 2005 | 19 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2008 | 234 | 0.060 |
Why?
|
Inflammation | 2 | 2023 | 1076 | 0.060 |
Why?
|
Dairy Products | 1 | 2005 | 27 | 0.060 |
Why?
|
Warfarin | 1 | 2006 | 108 | 0.060 |
Why?
|
Single-Blind Method | 1 | 2005 | 131 | 0.060 |
Why?
|
Meat | 1 | 2005 | 44 | 0.060 |
Why?
|
Mice | 4 | 2023 | 10088 | 0.060 |
Why?
|
Somatoform Disorders | 1 | 2004 | 13 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2008 | 798 | 0.060 |
Why?
|
Hypotension | 1 | 2005 | 46 | 0.060 |
Why?
|
Body Image | 1 | 2004 | 28 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2008 | 602 | 0.060 |
Why?
|
Point-of-Care Testing | 1 | 2024 | 38 | 0.060 |
Why?
|
Cerebral Hemorrhage | 1 | 2005 | 84 | 0.060 |
Why?
|
Hierarchy, Social | 1 | 2004 | 1 | 0.060 |
Why?
|
Dominance-Subordination | 1 | 2004 | 2 | 0.060 |
Why?
|
Oncorhynchus mykiss | 1 | 2004 | 2 | 0.060 |
Why?
|
Life Change Events | 1 | 2004 | 65 | 0.060 |
Why?
|
Mental Disorders | 2 | 2014 | 762 | 0.060 |
Why?
|
Lipocalin-2 | 1 | 2023 | 8 | 0.060 |
Why?
|
alpha-Fetoproteins | 1 | 2023 | 14 | 0.060 |
Why?
|
Aggression | 1 | 2004 | 57 | 0.060 |
Why?
|
Censuses | 1 | 2023 | 14 | 0.060 |
Why?
|
Prednisone | 1 | 2024 | 78 | 0.060 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 2023 | 19 | 0.060 |
Why?
|
Motor Activity | 1 | 2006 | 337 | 0.060 |
Why?
|
Asthma | 1 | 2008 | 397 | 0.060 |
Why?
|
Tryptophan | 1 | 2023 | 50 | 0.060 |
Why?
|
Systole | 4 | 1998 | 108 | 0.060 |
Why?
|
Thyroid Function Tests | 1 | 2023 | 13 | 0.060 |
Why?
|
Infusions, Intravenous | 4 | 2005 | 169 | 0.060 |
Why?
|
Tyrosine | 1 | 2023 | 93 | 0.050 |
Why?
|
Ovariectomy | 1 | 2023 | 98 | 0.050 |
Why?
|
Thyrotropin | 1 | 2023 | 33 | 0.050 |
Why?
|
Proteome | 1 | 2024 | 132 | 0.050 |
Why?
|
Migraine Disorders | 1 | 2003 | 44 | 0.050 |
Why?
|
Glucose Intolerance | 1 | 2004 | 88 | 0.050 |
Why?
|
Psychometrics | 3 | 2016 | 351 | 0.050 |
Why?
|
Risk | 3 | 2017 | 368 | 0.050 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2023 | 60 | 0.050 |
Why?
|
Hospitals | 2 | 2017 | 367 | 0.050 |
Why?
|
Hysterectomy | 1 | 2023 | 71 | 0.050 |
Why?
|
Survival Analysis | 2 | 2019 | 546 | 0.050 |
Why?
|
Caspase 1 | 1 | 2023 | 104 | 0.050 |
Why?
|
Methylprednisolone | 1 | 2022 | 28 | 0.050 |
Why?
|
Virus Shedding | 1 | 2022 | 17 | 0.050 |
Why?
|
Leukocidins | 1 | 2022 | 8 | 0.050 |
Why?
|
Exotoxins | 1 | 2022 | 9 | 0.050 |
Why?
|
Depressive Disorder | 1 | 2005 | 291 | 0.050 |
Why?
|
Lipoproteins | 2 | 2006 | 83 | 0.050 |
Why?
|
Receptors, Interleukin-1 | 1 | 2022 | 64 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2023 | 303 | 0.050 |
Why?
|
Fever | 1 | 2022 | 63 | 0.050 |
Why?
|
Polymerase Chain Reaction | 1 | 2023 | 490 | 0.050 |
Why?
|
Bacterial Toxins | 1 | 2022 | 59 | 0.050 |
Why?
|
Chi-Square Distribution | 3 | 2017 | 410 | 0.050 |
Why?
|
Vero Cells | 1 | 2021 | 73 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2021 | 2003 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2002 | 268 | 0.050 |
Why?
|
Interleukin-1beta | 1 | 2023 | 259 | 0.050 |
Why?
|
Anticonvulsants | 1 | 2022 | 91 | 0.050 |
Why?
|
Viral Load | 1 | 2022 | 223 | 0.050 |
Why?
|
Reference Standards | 1 | 2021 | 62 | 0.050 |
Why?
|
Health Education | 1 | 2003 | 184 | 0.050 |
Why?
|
Healthy Volunteers | 1 | 2021 | 69 | 0.050 |
Why?
|
Adrenal Cortex Hormones | 1 | 2022 | 122 | 0.050 |
Why?
|
Complement Factor D | 1 | 2020 | 4 | 0.050 |
Why?
|
Complement C5 | 1 | 2020 | 9 | 0.050 |
Why?
|
Complement C4 | 1 | 2020 | 12 | 0.050 |
Why?
|
Complement C2 | 1 | 2020 | 9 | 0.050 |
Why?
|
NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 248 | 0.050 |
Why?
|
Complement Factor B | 1 | 2020 | 11 | 0.050 |
Why?
|
Rumen | 1 | 2020 | 1 | 0.050 |
Why?
|
Glucose-6-Phosphatase | 1 | 2020 | 15 | 0.050 |
Why?
|
Prenatal Care | 2 | 2020 | 180 | 0.050 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2021 | 188 | 0.050 |
Why?
|
Staphylococcus aureus | 1 | 2022 | 156 | 0.050 |
Why?
|
Antigens, Viral | 1 | 2021 | 131 | 0.050 |
Why?
|
Models, Statistical | 2 | 2017 | 308 | 0.050 |
Why?
|
Social Class | 2 | 2002 | 120 | 0.050 |
Why?
|
Complement C3 | 1 | 2020 | 61 | 0.050 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2021 | 73 | 0.050 |
Why?
|
Stifle | 1 | 2020 | 2 | 0.050 |
Why?
|
Colorado | 1 | 2020 | 19 | 0.050 |
Why?
|
Osteotomy | 1 | 2020 | 14 | 0.050 |
Why?
|
Genetic Markers | 1 | 2020 | 114 | 0.050 |
Why?
|
Mitral Valve | 1 | 2021 | 96 | 0.040 |
Why?
|
Crosses, Genetic | 1 | 2000 | 105 | 0.040 |
Why?
|
Spouses | 1 | 2020 | 38 | 0.040 |
Why?
|
Energy Metabolism | 2 | 2017 | 342 | 0.040 |
Why?
|
Thrombelastography | 1 | 2020 | 5 | 0.040 |
Why?
|
Chlorides | 1 | 2000 | 31 | 0.040 |
Why?
|
Restraint, Physical | 1 | 2000 | 31 | 0.040 |
Why?
|
Keratin-18 | 1 | 2019 | 2 | 0.040 |
Why?
|
Seroma | 1 | 2019 | 8 | 0.040 |
Why?
|
Urinary Bladder Neoplasms | 2 | 1992 | 54 | 0.040 |
Why?
|
New Jersey | 1 | 2019 | 26 | 0.040 |
Why?
|
Splenectomy | 1 | 2020 | 41 | 0.040 |
Why?
|
Neurokinin A | 1 | 1999 | 7 | 0.040 |
Why?
|
Lactic Acid | 1 | 2000 | 69 | 0.040 |
Why?
|
Texas | 1 | 2019 | 55 | 0.040 |
Why?
|
Signal Transduction | 2 | 2021 | 2850 | 0.040 |
Why?
|
Surgical Wound | 1 | 2019 | 10 | 0.040 |
Why?
|
Substance P | 1 | 1999 | 45 | 0.040 |
Why?
|
Smokers | 1 | 2020 | 90 | 0.040 |
Why?
|
Cell Death | 1 | 2021 | 264 | 0.040 |
Why?
|
Brain Chemistry | 1 | 1999 | 80 | 0.040 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 2 | 2013 | 123 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2019 | 37 | 0.040 |
Why?
|
Urban Population | 2 | 2011 | 183 | 0.040 |
Why?
|
Patient Outcome Assessment | 1 | 2019 | 52 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 24 | 0.040 |
Why?
|
Midazolam | 1 | 1999 | 12 | 0.040 |
Why?
|
Vision Disorders | 1 | 2019 | 43 | 0.040 |
Why?
|
Functional Neuroimaging | 1 | 2019 | 15 | 0.040 |
Why?
|
Perioperative Care | 1 | 2019 | 73 | 0.040 |
Why?
|
Inflammasomes | 1 | 2023 | 315 | 0.040 |
Why?
|
Anesthetics, Intravenous | 1 | 1999 | 27 | 0.040 |
Why?
|
Galanin | 1 | 1999 | 4 | 0.040 |
Why?
|
Tachykinins | 1 | 1999 | 9 | 0.040 |
Why?
|
Home Care Services | 1 | 2020 | 97 | 0.040 |
Why?
|
Frail Elderly | 1 | 2019 | 110 | 0.040 |
Why?
|
Ischemic Attack, Transient | 1 | 2019 | 89 | 0.040 |
Why?
|
Disease Outbreaks | 1 | 2019 | 103 | 0.040 |
Why?
|
Lung | 1 | 2023 | 707 | 0.040 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2019 | 52 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2019 | 83 | 0.040 |
Why?
|
Animal Feed | 2 | 1998 | 16 | 0.040 |
Why?
|
Phosphorylation | 1 | 2021 | 855 | 0.040 |
Why?
|
Biometry | 1 | 1998 | 12 | 0.040 |
Why?
|
Cell Membrane | 1 | 2021 | 489 | 0.040 |
Why?
|
Canada | 2 | 2009 | 141 | 0.040 |
Why?
|
Models, Biological | 2 | 2017 | 1132 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2013 | 385 | 0.040 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2017 | 2 | 0.040 |
Why?
|
Transcriptome | 1 | 2021 | 305 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 447 | 0.040 |
Why?
|
Urinalysis | 1 | 2017 | 33 | 0.040 |
Why?
|
Anion Transport Proteins | 1 | 2017 | 3 | 0.040 |
Why?
|
Parturition | 1 | 2017 | 51 | 0.040 |
Why?
|
Protective Factors | 1 | 2017 | 33 | 0.040 |
Why?
|
Independent Living | 1 | 2017 | 43 | 0.040 |
Why?
|
Sex Ratio | 1 | 1997 | 9 | 0.040 |
Why?
|
Carrier State | 1 | 2017 | 17 | 0.040 |
Why?
|
Gene Expression | 1 | 2020 | 801 | 0.040 |
Why?
|
Vitamin D | 2 | 2010 | 147 | 0.040 |
Why?
|
Telephone | 1 | 2018 | 125 | 0.040 |
Why?
|
Body Surface Area | 1 | 2017 | 13 | 0.040 |
Why?
|
Academic Medical Centers | 1 | 2019 | 312 | 0.040 |
Why?
|
Apolipoproteins | 1 | 1997 | 16 | 0.040 |
Why?
|
Organizational Policy | 1 | 2017 | 54 | 0.040 |
Why?
|
Computer Simulation | 1 | 2019 | 446 | 0.040 |
Why?
|
Chemokine CXCL10 | 1 | 2017 | 53 | 0.030 |
Why?
|
Diastole | 4 | 1998 | 88 | 0.030 |
Why?
|
Adolescent Nutritional Physiological Phenomena | 2 | 2007 | 7 | 0.030 |
Why?
|
Cost-Benefit Analysis | 2 | 2014 | 288 | 0.030 |
Why?
|
Personality Inventory | 1 | 1996 | 50 | 0.030 |
Why?
|
School Nursing | 1 | 2016 | 26 | 0.030 |
Why?
|
20-alpha-Dihydroprogesterone | 1 | 2016 | 9 | 0.030 |
Why?
|
Desoxycorticosterone | 1 | 2016 | 9 | 0.030 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 1996 | 32 | 0.030 |
Why?
|
Anxiety | 1 | 2019 | 389 | 0.030 |
Why?
|
Antibody Affinity | 1 | 2016 | 18 | 0.030 |
Why?
|
Paralysis | 1 | 2016 | 15 | 0.030 |
Why?
|
Guinea Pigs | 1 | 2016 | 103 | 0.030 |
Why?
|
Receptors, GABA-A | 1 | 2016 | 26 | 0.030 |
Why?
|
Horses | 1 | 2016 | 48 | 0.030 |
Why?
|
Linear Models | 1 | 2017 | 425 | 0.030 |
Why?
|
Pregnanolone | 1 | 2016 | 27 | 0.030 |
Why?
|
Food | 2 | 2008 | 80 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2021 | 1962 | 0.030 |
Why?
|
Patient Discharge | 1 | 2020 | 473 | 0.030 |
Why?
|
Procollagen | 1 | 2015 | 9 | 0.030 |
Why?
|
Child Welfare | 1 | 1996 | 54 | 0.030 |
Why?
|
Dependovirus | 1 | 2022 | 647 | 0.030 |
Why?
|
Collagen Type I | 1 | 2015 | 31 | 0.030 |
Why?
|
Heart Rate | 2 | 2008 | 298 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 94 | 0.030 |
Why?
|
Adenosine Triphosphatases | 1 | 2017 | 241 | 0.030 |
Why?
|
Genetic Therapy | 1 | 2022 | 701 | 0.030 |
Why?
|
Spine | 1 | 2015 | 44 | 0.030 |
Why?
|
Mothers | 2 | 1996 | 256 | 0.030 |
Why?
|
Femur | 1 | 2015 | 53 | 0.030 |
Why?
|
Androstenedione | 2 | 2006 | 8 | 0.030 |
Why?
|
General Surgery | 2 | 1974 | 196 | 0.030 |
Why?
|
Psychology | 1 | 2015 | 48 | 0.030 |
Why?
|
Bronchography | 1 | 2014 | 2 | 0.030 |
Why?
|
Leukomalacia, Periventricular | 2 | 2005 | 10 | 0.030 |
Why?
|
Population Density | 1 | 1974 | 12 | 0.030 |
Why?
|
Patient Isolation | 1 | 2014 | 7 | 0.030 |
Why?
|
Enterovirus B, Human | 1 | 2014 | 17 | 0.030 |
Why?
|
Brassica | 1 | 1994 | 7 | 0.030 |
Why?
|
Menarche | 2 | 2006 | 34 | 0.030 |
Why?
|
Arm | 1 | 1994 | 39 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2019 | 2082 | 0.030 |
Why?
|
Blood Volume | 1 | 1994 | 41 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2016 | 441 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2014 | 99 | 0.030 |
Why?
|
Survival Rate | 2 | 2013 | 792 | 0.030 |
Why?
|
Sheep | 1 | 1994 | 166 | 0.030 |
Why?
|
Metabolism | 1 | 2013 | 14 | 0.030 |
Why?
|
Hallucinations | 1 | 2013 | 16 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2013 | 37 | 0.030 |
Why?
|
Technetium | 1 | 2013 | 68 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2015 | 345 | 0.030 |
Why?
|
Injections | 1 | 2013 | 77 | 0.030 |
Why?
|
Educational Measurement | 1 | 2015 | 203 | 0.030 |
Why?
|
Drug Interactions | 1 | 2013 | 112 | 0.030 |
Why?
|
Program Evaluation | 1 | 2016 | 475 | 0.030 |
Why?
|
Drug Resistance, Multiple, Viral | 1 | 2013 | 14 | 0.030 |
Why?
|
Safety | 2 | 2008 | 140 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2013 | 96 | 0.030 |
Why?
|
Hemodynamics | 1 | 1994 | 207 | 0.030 |
Why?
|
Women's Health | 1 | 1996 | 388 | 0.030 |
Why?
|
Digestion | 1 | 1994 | 127 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 130 | 0.030 |
Why?
|
Tandem Repeat Sequences | 1 | 2012 | 27 | 0.030 |
Why?
|
Radio | 1 | 2012 | 2 | 0.030 |
Why?
|
Gene Duplication | 1 | 2012 | 32 | 0.030 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2012 | 25 | 0.030 |
Why?
|
Cytarabine | 1 | 2012 | 34 | 0.030 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1992 | 20 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 1132 | 0.030 |
Why?
|
Water | 1 | 1994 | 292 | 0.030 |
Why?
|
Homeostasis | 2 | 2005 | 330 | 0.030 |
Why?
|
Glycoproteins | 1 | 2013 | 198 | 0.030 |
Why?
|
Smoking | 3 | 2008 | 781 | 0.030 |
Why?
|
Treatment Failure | 1 | 2012 | 180 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2012 | 226 | 0.030 |
Why?
|
Biopsy | 1 | 2013 | 357 | 0.030 |
Why?
|
Global Health | 1 | 2013 | 151 | 0.030 |
Why?
|
Ferritins | 2 | 2003 | 31 | 0.030 |
Why?
|
Peptides | 1 | 2015 | 542 | 0.020 |
Why?
|
Curriculum | 1 | 2015 | 534 | 0.020 |
Why?
|
Apolipoproteins B | 2 | 2003 | 21 | 0.020 |
Why?
|
Coronary Disease | 2 | 1998 | 256 | 0.020 |
Why?
|
Transcription Factors | 1 | 2019 | 1451 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2010 | 45 | 0.020 |
Why?
|
Base Sequence | 1 | 2013 | 1316 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2013 | 473 | 0.020 |
Why?
|
Sampling Studies | 2 | 2003 | 66 | 0.020 |
Why?
|
Culture | 1 | 2011 | 75 | 0.020 |
Why?
|
Neutropenia | 1 | 2010 | 66 | 0.020 |
Why?
|
Phenotype | 2 | 2008 | 1124 | 0.020 |
Why?
|
Income | 3 | 2002 | 159 | 0.020 |
Why?
|
Climate | 1 | 2009 | 5 | 0.020 |
Why?
|
Atmospheric Pressure | 1 | 2009 | 2 | 0.020 |
Why?
|
Anti-HIV Agents | 1 | 2011 | 152 | 0.020 |
Why?
|
Medical Audit | 1 | 2010 | 59 | 0.020 |
Why?
|
Wind | 1 | 2009 | 3 | 0.020 |
Why?
|
Postural Balance | 1 | 2010 | 62 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2013 | 1333 | 0.020 |
Why?
|
Angina Pectoris | 1 | 2009 | 35 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 393 | 0.020 |
Why?
|
Cold Temperature | 1 | 2009 | 49 | 0.020 |
Why?
|
Legal Guardians | 1 | 2009 | 7 | 0.020 |
Why?
|
Fetus | 1 | 2009 | 96 | 0.020 |
Why?
|
RNA, Viral | 1 | 2010 | 265 | 0.020 |
Why?
|
Self Care | 1 | 2011 | 213 | 0.020 |
Why?
|
Adolescent Development | 1 | 2009 | 14 | 0.020 |
Why?
|
Estrus | 1 | 1988 | 27 | 0.020 |
Why?
|
Obstetrical Forceps | 1 | 1988 | 2 | 0.020 |
Why?
|
Butorphanol | 1 | 1988 | 4 | 0.020 |
Why?
|
Seasons | 1 | 2009 | 138 | 0.020 |
Why?
|
Apgar Score | 1 | 1988 | 11 | 0.020 |
Why?
|
Anesthesia, Intravenous | 1 | 1988 | 14 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 1999 | 196 | 0.020 |
Why?
|
Suction | 1 | 2008 | 30 | 0.020 |
Why?
|
Poverty | 1 | 2011 | 292 | 0.020 |
Why?
|
Adaptation, Psychological | 2 | 2004 | 262 | 0.020 |
Why?
|
France | 1 | 2008 | 11 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2009 | 195 | 0.020 |
Why?
|
United Kingdom | 1 | 2008 | 64 | 0.020 |
Why?
|
Temperature | 1 | 2009 | 298 | 0.020 |
Why?
|
Siblings | 1 | 2008 | 45 | 0.020 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2007 | 16 | 0.020 |
Why?
|
Chronic Disease | 1 | 2011 | 721 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2009 | 163 | 0.020 |
Why?
|
Observer Variation | 1 | 2008 | 193 | 0.020 |
Why?
|
Vitamin A | 1 | 2007 | 26 | 0.020 |
Why?
|
Sweden | 1 | 2007 | 40 | 0.020 |
Why?
|
Risk-Taking | 1 | 2008 | 157 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2009 | 254 | 0.020 |
Why?
|
Cisplatin | 1 | 1987 | 119 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2011 | 413 | 0.020 |
Why?
|
Magnesium | 1 | 2007 | 58 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2014 | 677 | 0.020 |
Why?
|
Medical Staff, Hospital | 1 | 2007 | 57 | 0.020 |
Why?
|
Erythrocyte Indices | 1 | 2006 | 4 | 0.020 |
Why?
|
Calcium | 1 | 2010 | 549 | 0.020 |
Why?
|
Fetal Hemoglobin | 1 | 2006 | 9 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2006 | 32 | 0.020 |
Why?
|
Dihydrotestosterone | 1 | 2006 | 17 | 0.020 |
Why?
|
Nursing Staff, Hospital | 1 | 2007 | 71 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2006 | 95 | 0.020 |
Why?
|
Intubation, Intratracheal | 1 | 2008 | 184 | 0.020 |
Why?
|
Virginia | 1 | 2005 | 16 | 0.020 |
Why?
|
Seawater | 1 | 1985 | 8 | 0.020 |
Why?
|
Gills | 1 | 1985 | 5 | 0.020 |
Why?
|
Fresh Water | 1 | 1985 | 10 | 0.020 |
Why?
|
Epidemiologic Studies | 1 | 2005 | 39 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 1999 | 1576 | 0.020 |
Why?
|
Dietary Sucrose | 1 | 2006 | 29 | 0.020 |
Why?
|
Rest | 1 | 1985 | 41 | 0.020 |
Why?
|
Twins | 1 | 2005 | 52 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 1999 | 1974 | 0.020 |
Why?
|
Phobic Disorders | 1 | 2005 | 15 | 0.020 |
Why?
|
Goals | 1 | 2006 | 86 | 0.020 |
Why?
|
Maternal Age | 1 | 2005 | 34 | 0.020 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2005 | 26 | 0.020 |
Why?
|
Software | 1 | 2008 | 351 | 0.020 |
Why?
|
Respiration | 1 | 2005 | 84 | 0.020 |
Why?
|
Personality Assessment | 1 | 2004 | 21 | 0.020 |
Why?
|
Internal-External Control | 1 | 2004 | 32 | 0.020 |
Why?
|
Hyperphagia | 1 | 2004 | 17 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2004 | 73 | 0.020 |
Why?
|
Mutation | 1 | 2012 | 2404 | 0.010 |
Why?
|
Infant Mortality | 1 | 2004 | 19 | 0.010 |
Why?
|
Individuality | 1 | 2004 | 21 | 0.010 |
Why?
|
Syndrome | 1 | 2004 | 167 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1985 | 574 | 0.010 |
Why?
|
Intracranial Hemorrhages | 1 | 2004 | 53 | 0.010 |
Why?
|
Cross-Cultural Comparison | 1 | 2004 | 44 | 0.010 |
Why?
|
Apolipoprotein A-II | 1 | 2003 | 4 | 0.010 |
Why?
|
Hormone Replacement Therapy | 1 | 2003 | 33 | 0.010 |
Why?
|
Apolipoprotein A-I | 1 | 2003 | 22 | 0.010 |
Why?
|
Genitalia, Female | 1 | 2003 | 20 | 0.010 |
Why?
|
Acute Disease | 1 | 2005 | 644 | 0.010 |
Why?
|
Estrone | 1 | 2003 | 12 | 0.010 |
Why?
|
Dehydroepiandrosterone | 1 | 2003 | 14 | 0.010 |
Why?
|
Psychological Tests | 1 | 2003 | 50 | 0.010 |
Why?
|
Vitamin E | 1 | 2003 | 54 | 0.010 |
Why?
|
Registries | 1 | 2005 | 788 | 0.010 |
Why?
|
Electric Impedance | 1 | 2001 | 34 | 0.010 |
Why?
|
Learning | 1 | 2003 | 171 | 0.010 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2000 | 23 | 0.010 |
Why?
|
Hematocrit | 2 | 1994 | 34 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2005 | 361 | 0.010 |
Why?
|
Algorithms | 1 | 2005 | 964 | 0.010 |
Why?
|
Child Development | 1 | 2001 | 77 | 0.010 |
Why?
|
Trout | 1 | 1999 | 5 | 0.010 |
Why?
|
Sequence Homology | 1 | 1999 | 18 | 0.010 |
Why?
|
Molecular Weight | 1 | 1999 | 187 | 0.010 |
Why?
|
Practice Patterns, Physicians' | 1 | 2005 | 712 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1999 | 55 | 0.010 |
Why?
|
Dairying | 1 | 1998 | 1 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 1999 | 281 | 0.010 |
Why?
|
Social Desirability | 1 | 1997 | 7 | 0.010 |
Why?
|
Hemoglobinometry | 1 | 1997 | 2 | 0.010 |
Why?
|
Minerals | 1 | 1997 | 19 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1997 | 103 | 0.010 |
Why?
|
Folic Acid | 1 | 1997 | 58 | 0.010 |
Why?
|
Automatism | 1 | 1996 | 1 | 0.010 |
Why?
|
Defense Mechanisms | 1 | 1996 | 5 | 0.010 |
Why?
|
Personality Disorders | 1 | 1996 | 17 | 0.010 |
Why?
|
Temperance | 1 | 1996 | 13 | 0.010 |
Why?
|
Television | 1 | 1996 | 22 | 0.010 |
Why?
|
Leisure Activities | 1 | 1996 | 31 | 0.010 |
Why?
|
Erythrocytes | 1 | 1997 | 153 | 0.010 |
Why?
|
South Carolina | 1 | 1996 | 14 | 0.010 |
Why?
|
Health Surveys | 1 | 1997 | 305 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 1997 | 198 | 0.010 |
Why?
|
Blood Pressure Determination | 1 | 1996 | 42 | 0.010 |
Why?
|
Health Status Indicators | 1 | 1996 | 96 | 0.010 |
Why?
|
Ohio | 1 | 1994 | 26 | 0.010 |
Why?
|
Maryland | 1 | 1994 | 32 | 0.010 |
Why?
|
Schools | 1 | 1996 | 155 | 0.010 |
Why?
|
Poaceae | 1 | 1994 | 4 | 0.010 |
Why?
|
Sheep Diseases | 1 | 1994 | 4 | 0.010 |
Why?
|
Drinking | 1 | 1994 | 14 | 0.010 |
Why?
|
California | 1 | 1994 | 158 | 0.010 |
Why?
|
Cellulose | 1 | 1994 | 41 | 0.010 |
Why?
|
Feces | 1 | 1994 | 88 | 0.010 |
Why?
|
Thyroid Gland | 1 | 1994 | 77 | 0.010 |
Why?
|
Anemia | 1 | 1994 | 115 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1992 | 313 | 0.010 |
Why?
|
Radiation Injuries | 1 | 1987 | 58 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 1987 | 472 | 0.000 |
Why?
|
Dipyridamole | 1 | 1985 | 17 | 0.000 |
Why?
|
Leukocyte Count | 1 | 1985 | 88 | 0.000 |
Why?
|
Diuretics | 1 | 1985 | 58 | 0.000 |
Why?
|
Uric Acid | 1 | 1985 | 51 | 0.000 |
Why?
|
Foreign Medical Graduates | 1 | 1974 | 2 | 0.000 |
Why?
|
Legislation, Medical | 1 | 1974 | 4 | 0.000 |
Why?
|
Economics, Medical | 1 | 1974 | 4 | 0.000 |
Why?
|
Professional Practice | 1 | 1974 | 23 | 0.000 |
Why?
|
Certification | 1 | 1974 | 49 | 0.000 |
Why?
|
Specialization | 1 | 1974 | 73 | 0.000 |
Why?
|
Education, Medical | 1 | 1974 | 172 | 0.000 |
Why?
|